MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (I.E., Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2022
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve unaudited financial results (i.e., standalone & consolidated) of the company for the quarter ended 30th June 2022 MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 18th July, 2022, received from Registrar and Share Transfer Agent of the company (viz., Mas Services Limited), comprising information related to issuance of letter(s) of confirmation against duplicate share certificates in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 11th July, 2022, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) regarding loss of share certificates of the company. As required under SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January, 2022, the company shall issue 'Letter of Confirmation' to the shareholders after compliance of requisite formalities. MOREPEN LABORATORIES LTD. - 500288 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report of Trading by Insiders for trading in Company''s Shares/ Securities, the Trading Window will remain closed with effect from July 01, 2022 for the purpose of consideration and approval of unaudited financial results for the quarter ended June 30, 2022. During the aforesaid closed trading window period, the Designated Persons shall not trade in Company''s shares/ securities. The Trading Window shall remain closed till 48 hours after the announcement of the said financial results, when the information becomes generally available. MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that Mrs. Anju Suri (DIN: 00042033) vide her letter dated June 22, 2022 has resigned from the Board of the Company as Director (Non-Executive, Non-Independent) with effect from close of business hours of June 22, 2022. MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Allotment
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors at their meeting held today i.e., Friday, 27th day of May, 2022 (commenced at 05:00 P.M. and concluded at 06:00 P.M.), inter-alia, approved the allotment of 2,13,42,505 Equity Shares of Rs. 2/- each, at an issue price of Rs. 53.72 per share, pursuant to the conversion of 1,14,65,201, 0.01% Compulsorily Convertible Preference Shares ('CCPS') of Rs. 100/- each. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read along with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed herewith Annual Secretarial Compliance Report of Morepen Laboratories Limited, issued by Mr. Praveen Dua, Proprietor of M/s. PD and Associates, Practicing Company Secretary, for the year ended March 31, 2022. MOREPEN LABORATORIES LTD. - 500288 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, in connection to declaration of audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2022 on 5th May, 2022, please find enclosed disclosure of Related Party Transactions, for half year ended 31st March, 2022 (i.e., from 1st October, 2021 to 31st March, 2022). MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 17th May, 2022, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the company, comprising information related to issue of duplicate share certificates of the company. In compliance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, the Company has issued Letter(s) of Confirmation to the respective shareholders. MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find attached transcript of Investors and Analyst Conference Call organized on Friday, 6th May, 2022 at 04.00 P.M. (IST) subsequent to declaration of audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2022.